Thomas McCauley
Chief Scientific Officer · Stoke Therapeutics, Inc.
Individual
- 2026
- Jul 17, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Thomas McCauley files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Adrian R. Krainer - $3.90M in STOK purchases and sales in the last 12 months
- Barry Ticho - $1.88M in STOK purchases and sales in the last 12 months
- Jonathan Allan - $1.20M in STOK purchases and sales in the last 12 months
- Edward M. Md Kaye - $934K in STOK purchases and sales in the last 12 months
- Arthur Tzianabos - $174K in STOK purchases and sales in the last 12 months
- Thomas Leggett - $147K in STOK purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Thomas McCauley?
Thomas McCauley is a corporate insider, tracked as Chief Scientific Officer of Stoke Therapeutics, Inc. (STOK). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Thomas McCauley submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.